| NR4A2 |
NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 |
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
10.370 |
Evidence |
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
10.370 |
Evidence |
|
| HOXA10 |
HOXA10, HOX1H: Homeobox protein Hox-A10 |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
10.370 |
Evidence |
|
| MYL9 |
MYL9, MLC2, MRLC1, MYRL2: Myosin regulatory light chain 2, smooth muscle isoform |
GIT2 |
IPI00238218 |
10.370 |
Evidence |
|
| ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
CD82 |
CD82, KAI1, SAR2, ST6, TSPAN27: CD82 antigen |
10.370 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
10.370 |
Evidence |
|
| PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
PTPN1 |
PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 |
10.370 |
Evidence |
|
| CEBPB |
CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
10.370 |
Evidence |
|
| CAPN2 |
CAPN2, CANPL2: Calpain-2 catalytic subunit precursor |
GIT2 |
IPI00238218 |
10.370 |
Evidence |
|
| CREB1 |
CREB1: cAMP response element-binding protein |
ZNF335 |
ZNF335: Zinc finger protein 335 |
10.370 |
Evidence |
|
| CREB1 |
CREB1: cAMP response element-binding protein |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
10.370 |
Evidence |
|
| ETS1 |
ETS1, EWSR2: Protein C-ets-1 |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
10.370 |
Evidence |
|
| PSKH1 |
PSKH1: Serine/threonine-protein kinase H1 |
GIT2 |
IPI00238218 |
10.370 |
Evidence |
|
| GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
10.370 |
Evidence |
|
| SP1 |
SP1, TSFP1: Transcription factor Sp1 |
MIER1 |
MIER1, KIAA1610: Mesoderm induction early response protein 1 |
10.370 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
PSMA3 |
PSMA3, PSC8: Proteasome subunit alpha type-3 |
10.370 |
Evidence |
|
| JUN |
JUN: Transcription factor AP-1 |
MKNK1 |
MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 |
10.370 |
Evidence |
|
| JUN |
JUN: Transcription factor AP-1 |
RPS6KA2 |
RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 |
10.370 |
Evidence |
|
| PRKCG |
PRKCG, PKCG: Protein kinase C gamma type |
GIT2 |
IPI00238218 |
10.370 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
RASGRP2 |
RASGRP2: RAS guanyl-releasing protein 2 |
10.370 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
LRRC7 |
LRRC7, KIAA1365, LAP1: Leucine-rich repeat-containing protein 7 |
10.370 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
TSC2 |
TSC2, TSC4: Tuberin |
10.370 |
Evidence |
|
| NRAS |
NRAS, HRAS1: GTPase NRas precursor |
PRKACA |
PRKACA, PKACA: cAMP-dependent protein kinase, alpha-catalytic subunit |
10.370 |
Evidence |
|
| NRAS |
NRAS, HRAS1: GTPase NRas precursor |
RSU1 |
RSU1, RSP1: Ras suppressor protein 1 |
10.370 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
10.370 |
Evidence |
|